LPC
Lion Point Capital Portfolio holdings
AUM
$14.7M
This Quarter Return
+4.86%
1 Year Return
+16.78%
3 Year Return
+52.25%
5 Year Return
+189.95%
10 Year Return
–
AUM
$24.9M
AUM Growth
+$24.9M
(-22%)
Cap. Flow
-$8.97M
Cap. Flow
% of AUM
-35.99%
Top 10 Holdings %
Top 10 Hldgs %
78.38%
Holding
31
New
4
Increased
3
Reduced
8
Closed
5
Top Buys
| 1 |
Biohaven
BHVN
|
$1.77M |
| 2 |
BLUE
bluebird bio
BLUE
|
$468K |
| 3 |
Disc Medicine
IRON
|
$378K |
| 4 |
Benitec Biopharma
BNTC
|
$358K |
| 5 |
Arcutis Biotherapeutics
ARQT
|
$326K |
Top Sells
| 1 |
Ardelyx
ARDX
|
$3.35M |
| 2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$2.5M |
| 3 |
Insmed
INSM
|
$1.32M |
| 4 |
Neurocrine Biosciences
NBIX
|
$1.15M |
| 5 |
Kiniksa Pharmaceuticals
KNSA
|
$1.08M |
Sector Composition
| 1 | Healthcare | 94.86% |
| 2 | Technology | 0.17% |
| 3 | Communication Services | 0.07% |
| 4 | Consumer Discretionary | 0% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Insmed
INSM
$28.8B
| $3.81M | 8.49% |
52,200
-18,135
| -26% | -$1.32M |
|
2
Geron
GERN
$893M
| $2.86M | 6.37% |
630,000
| – | – |
|
|
3
Ardelyx
ARDX
$1.53B
| $2.55M | 5.68% |
370,000
-486,667
| -57% | -$3.35M |
|
4
Milestone Pharmaceuticals
MIST
$156M
| $2.51M | 5.6% |
1,654,154
-686,053
| -29% | -$1.04M |
|
|
5
Biohaven
BHVN
$1.63B
| $1.77M | 3.94% |
+35,400
| New | +$1.77M |
|
|
6
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $1.53M | 3.42% |
61,400
-43,291
| -41% | -$1.08M |
|
7
BridgeBio Pharma
BBIO
$9.89B
| $1.25M | 2.78% |
49,000
| – | – |
|
|
MRNS
8
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.22M | 2.72% |
693,778
-1,421,049
| -67% | -$2.5M |
|
9
Fennec Pharmaceuticals
FENC
$247M
| $1.08M | 2.39% |
215,000
+45,000
| +26% | +$225K |
|
10
Mineralys Therapeutics
MLYS
$1.03B
| $957K | 2.13% |
79,000
| – | – |
|
11
Syndax Pharmaceuticals
SNDX
$1.41B
| $889K | 1.98% |
46,200
-18,800
| -29% | -$362K |
|
|
AVDL
12
Avadel Pharmaceuticals
AVDL
$1.43B
| $839K | 1.87% |
64,000
-18,500
| -22% | -$243K |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| $820K | 1.83% |
1,578,256
+900,000
| +133% | +$468K |
|
14
Regenxbio
RGNX
$451M
| $606K | 1.35% |
57,750
+21,500
| +59% | +$226K |
|
15
Jasper Therapeutics
JSPR
$45.5M
| $602K | 1.34% |
32,000
| – | – |
|
|
16
Disc Medicine
IRON
$2.07B
| $378K | 0.84% |
+7,700
| New | +$378K |
|
|
17
Benitec Biopharma
BNTC
$348M
| $358K | 0.8% |
+39,000
| New | +$358K |
|
|
18
Arcutis Biotherapeutics
ARQT
$1.86B
| $326K | 0.73% |
+35,100
| New | +$326K |
|
19
Seres Therapeutics
MCRB
$166M
| $322K | 0.72% |
340,761
| – | – |
|
|
LUMO
20
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $153K | 0.34% |
39,589
-51,205
| -56% | -$198K |
|
21
Microsoft
MSFT
$3.77T
| $43K | 0.1% |
100
| – | – |
|
|
SPRB
22
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $35.6K | 0.08% |
75,000
| – | – |
|
23
Alphabet (Google) Class C
GOOG
$2.58T
| $16.7K | 0.04% |
100
| – | – |
|
24
Battalion Oil
BATL
$19.4M
| – | – |
-7,423
| Closed | -$24.8K |
|
25
iShares Russell 2000 ETF
IWM
$67B
| – | – |
0
| – | – |
|